The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Goldman Sachs ActiveBeta® Europe Eq ETF GSEU
Morningstar’s Analysis GSEU
Will GSEU outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 3.67 | 999,035 | Healthcare |
ASML Holding NV | 2.73 | 743,013 | Technology |
Nestle SA | 1.97 | 535,837 | Consumer Defensive |
Novartis AG Registered Shares | 1.88 | 512,054 | Healthcare |
Roche Holding AG | 1.86 | 506,208 | Healthcare |
AstraZeneca PLC | 1.82 | 494,756 | Healthcare |
Shell PLC | 1.65 | 447,798 | Energy |
SAP SE | 1.65 | 447,789 | Technology |
Lvmh Moet Hennessy Louis Vuitton SE | 1.51 | 411,598 | Consumer Cyclical |
TotalEnergies SE | 1.24 | 336,291 | Energy |